Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.92 USD | +4.78% | +17.23% | -19.13% |
Financials (USD)
Sales 2024 * | 23.95M | Sales 2025 * | 72.18M | Capitalization | 240M |
---|---|---|---|---|---|
Net income 2024 * | -76M | Net income 2025 * | -39M | EV / Sales 2024 * | 10 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.32 x |
P/E ratio 2024 * |
-3.64
x | P/E ratio 2025 * |
-7.15
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.45% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +6.20% | ||
1 week | +13.91% | ||
Current month | +7.21% | ||
1 month | -0.35% | ||
3 months | -20.98% | ||
6 months | +47.91% | ||
Current year | -22.81% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 5.92 | +4.78% | 88 454 |
24-03-27 | 5.65 | +6.20% | 210,561 |
24-03-26 | 5.32 | +5.14% | 404,423 |
24-03-25 | 5.06 | +1.00% | 246,107 |
24-03-22 | 5.01 | -0.79% | 67,363 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 240M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.77% | 210B | |
+1.02% | 210B | |
-6.61% | 201B | |
-3.51% | 157B |